The Effects of Disease-Modifying Therapies on Optic Nerve Degeneration in Multiple Sclerosis.

Eur J Neurol · 2025 · PMC11883414 · PMID 40047132

Europe PMC DOI

hedged sentence

0.8700

closest p · 17.4× alpha

0.8700

boldest claim

The sentences

did not reach statistical significancep = 0.87not close (p > 0.1)

However, the difference in annualized RNFL thinning between the H‐DMTs and M‐DMTs cohorts did not reach statistical significance ( p = 0.87).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.